XML 14 R3.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
REVENUES $ 679 $ 1,692
COST OF REVENUES (523) (282)
GROSS PROFIT 156 1,410
RESEARCH AND DEVELOPMENT EXPENSES [1] (7,334) (6,100)
Less - grants 1,309 1,128
RESEARCH AND DEVELOPMENT EXPENSES, NET (6,025) (4,972)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES [1] (1,995) (1,822)
OPERATING LOSS (7,864) (5,384)
FINANCIAL EXPENSES (904) (1,157)
FINANCIAL INCOME 242 28
FINANCIAL EXPENSES - NET (662) (1,129)
LOSS FROM CONTINUING OPERATIONS (8,526) (6,513)
INCOME (LOSS) FROM DISCONTINUED OPERATIONS (72) 541
NET LOSS FOR THE PERIOD $ (8,598) $ (5,972)
NET LOSS PER SHARE OF COMMON STOCK - BASIC AND DILUTED    
Loss from continuing operations (in dollars per share) $ (0.09) $ (0.07)
Income from discontinued operations (in dollars per share) (0.00) 0.01
Net loss per share of common stock (in dollars per share) $ (0.09) $ (0.06)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE-BASIC AND DILUTED (in shares) 99,715,625 93,200,739
[1] Includes share-based compensation